Lax 510(k) Labeling Rules Alleged By Citizen Petition Citing Lumenis Device
This article was originally published in The Gray Sheet
Executive Summary
Labeling for 510(k)-cleared devices should include a notice informing consumers that FDA sign-off is based on applicant claims not verified by the agency, according to an Oct. 4 citizen petition
You may also be interested in...
ClearLight Acne Treatment DTC Advertising Will Follow More Laser Placement
Lumenis plans to launch a direct-to-consumer advertising campaign by the first quarter of 2003 in support of its ClearLight laser acne treatment system, which received FDA 510(k) clearance on Aug. 19
ESC Medical $203 Mil. Deal Ensures Coherent Ophthalmic Laser Portfolio
ESC Medical Systems' $203 mil. purchase of Coherent Medical Group gives it an entry into the high-growth ophthalmic laser market and strengthens the Israeli firm's presence in the U.S.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.